Toxicologic testing of inhaled pharmaceutical aerosols

Area of Science:

• Pharmacology
• Toxicology
• Respiratory Medicine

Background:

• Inhalation drug toxicity testing shares general principles but presents unique challenges.
• Accurate dose determination and interspecies extrapolation are significant hurdles for inhaled pharmaceuticals.

Purpose of the Study:

• To review technical issues in the toxicologic testing of inhaled pharmaceuticals.
• To explore current and future challenges in this specialized area of drug safety evaluation.

Main Methods:

• Review of existing literature and methodologies for inhalation toxicity testing.
• Analysis of challenges related to dose metrics, exposure routes (oral vs. nasal), and animal models.
• Discussion of assessment strategies for local respiratory and systemic toxicity.

Main Results:

• Inhaled dose is difficult to determine accurately compared to oral or intravenous routes.
• Differences in human (mouth) versus animal (nose) inhalation patterns complicate exposure relevance.
• Assessing local respiratory toxicity and potential systemic effects requires specialized studies.

Conclusions:

• Novel approaches in exposure methodology and technology are needed for inhaled pharmaceuticals.
• Accurate toxicity testing requires careful consideration of respiratory tract deposition, lung cell damage, and pulmonary function.
• Future research should address the complexities of interspecies dose extrapolation and exposure relevance.